This warning applies to all medications containing semaglutide, including Wegovy, as well as other GLP-1 agonists like Ozempic and Rybelsus, which are used for Type 2 diabetes (and off-label for weight loss)
Source: Economic Times (Rica Bhattacharyya & Vikas Dandekar) #Semaglutide #GLP1 #Pharma #Generics #IndiaPharma #API To view or add a comment, sign in #LegendCapital #PortfolioNews Our portfolio company, Innovent Biologics, recently highlighted its 2025 financial achievements and its strategic outlook for 2026 in an exclusive interview with Bloomberg
Research category: Copper peptide / extracellular matrix research compound
(2014) www.sciencedaily.com From the publication: The cross-sectional prospective study published in JCEM examined testosterone levels and key atherosclerotic markers, including intimal media thickening of the layers in the carotid artery, the presence of atherosclerotic plaques, function of the endothelial cells that line the heart and blood vessels, and inflammatory markers in 115 men with Type 2 diabetes
In sensitive individuals, sustained elevation may cause gynecomastia or reproductive effects These hormonal effects are generally not observed at doses of 100 mcg or below Theoretical/Long-Term: Potential effects on glucose metabolism and insulin sensitivity with prolonged use As with all GH-elevating compounds, theoretical concern regarding promotion of growth in undiagnosed malignancies Water retention and tingling typically diminish within the first few weeks as the body adapts
Luckily, FDA-approved alternatives like Zepbound, Oral Wegovy, and Foundayo generally have oral tirzepatide insurance coverage